Early use of tocilizumab in solid organ transplant recipients with COVID-19: A retrospective cohort study in Saudi Arabia.
Amani H YamaniBasem M AlraddadiReem S AlmaghrabiAfnan A AmerFatimah S MehdawiMohammed A Al-HamziMeshari S AldajaniMajda S AlattasAiman M Elsaed RamadanGhassan Y WaliAbeer N AlshukairiAbbas Al MutairPublished in: Immunity, inflammation and disease (2022)
Early use of tocilizumab in SOT was associated with a shorter hospital stay. There was no difference in mortality rate and the requirement for mechanical ventilation in both groups.
Keyphrases
- mechanical ventilation
- rheumatoid arthritis
- acute respiratory distress syndrome
- intensive care unit
- coronavirus disease
- juvenile idiopathic arthritis
- sars cov
- rheumatoid arthritis patients
- healthcare
- cardiovascular events
- respiratory failure
- risk factors
- type diabetes
- cardiovascular disease
- emergency department
- disease activity
- systemic lupus erythematosus
- coronary artery disease
- extracorporeal membrane oxygenation